{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:24:37Z","timestamp":1787156677150,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011012","name":"Gesellschaft f\u00fcr Thrombose- und H\u00e4mostaseforschung","doi-asserted-by":"publisher","award":["AP01104OFF"],"award-info":[{"award-number":["AP01104OFF"]}],"id":[{"id":"10.13039\/501100011012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtha.2026.06.023","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:41:50Z","timestamp":1782492110000},"page":"3256-3262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7176-2000","authenticated-orcid":false,"given":"Timothy","family":"Hoberstorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Nopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Englisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Kienzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Fritzer-Szekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.06.023_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2020.12.031","article-title":"Prediction models for recurrence and bleeding in patients with venous thromboembolism: a systematic review and critical appraisal","volume":"199","author":"de Winter","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.023_bib4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehac776","article-title":"Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score","volume":"44","author":"de Winter","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.06.023_bib5","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jtha.2023.04.043","article-title":"Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study","volume":"21","author":"Nopp","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.023_bib6","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehaf1002","article-title":"Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers","volume":"47","author":"Roy","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.06.023_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/biom14010038","article-title":"GDF-15 inhibits ADP-induced human platelet aggregation through the GFRAL\/RET signaling complex","volume":"14","author":"Xie","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtha.2026.06.023_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023847","article-title":"Growth differentiation factor 15 and risk of bleeding events: the atherosclerosis risk in communities study","volume":"12","author":"Mathews","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2026.06.023_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/a-1695-8327","article-title":"The prognostic potential of growth differentiation factor-15 on bleeding events and patient outcome after cardiac surgery\u2014a prospective cohort study","volume":"122","author":"Kazem","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.023_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaccao.2024.11.007","article-title":"Growth differentiation factor-15 predicts major bleeding in cancer patients: results from the Vienna CAT-BLED study","volume":"7","author":"Englisch","year":"2025","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtha.2026.06.023_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/jth.15559","article-title":"Growth differentiation factor-15 for prediction of bleeding in cancer patients","volume":"20","author":"Mulder","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.023_bib12","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/ndt\/gfac321","article-title":"Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study","volume":"38","author":"Nopp","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jtha.2026.06.023_bib13","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2026.06.023_bib14","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.jtha.2024.05.031","article-title":"Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study","volume":"22","author":"Guman","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.023_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2022.11.006","article-title":"The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: construct validity and responsiveness in a prospective cohort study","volume":"221","author":"Steiner","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.023_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jtha.2025.05.005","volume":"24","author":"Hoberstorfer","year":"2026","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.023_bib17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.06.023_bib20","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.023_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.023_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/bio.2018.0032","article-title":"Usage data and scientific impact of the prospectively established fluid bioresources at the hospital-based MedUni Wien Biobank","volume":"16","author":"Haslacher","year":"2018","journal-title":"Biopreserv Biobank"},{"key":"10.1016\/j.jtha.2026.06.023_bib23","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.jtha.2025.08.007","article-title":"External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the Registro Informatizado Enfermedad TromboEmb\u1f40lica Registry","volume":"23","author":"Hoberstorfer","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.06.023_bib24","author":"Harrell"},{"key":"10.1016\/j.jtha.2026.06.023_bib31","series-title":"rms: regression modeling strategies, R package version 8.1-0","author":"Harrell","year":"2025"},{"key":"10.1016\/j.jtha.2026.06.023_bib33","series-title":"A Package for Survival Analysis in R. R package version 3.8-6","author":"Therneau","year":"2026"},{"key":"10.1016\/j.jtha.2026.06.023_bib34","series-title":"Modeling survival data: extending the cox model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.jtha.2026.06.023_bib32","series-title":"Tidycmprsk: Competing Risks Estimation, R package version 1.1.1","author":"Sjoberg","year":"2025"},{"key":"10.1016\/j.jtha.2026.06.023_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.01.022","article-title":"GDF-15 is associated with thrombus burden in patients with deep venous thrombosis","volume":"187","author":"Liang","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.06.023_bib28","first-page":"757","article-title":"Plasma growth differentiation factor 15 levels for predicting serious adverse events and bleeding in acute pulmonary embolism: a prospective observational study","volume":"130","author":"Skowro\u0144ska","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jtha.2026.06.023_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13660","article-title":"Isoprostane-8 and GDF-15 as novel markers of post-PE syndrome: relation with prothrombotic factors","volume":"52","author":"Z\u0105bczyk","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jtha.2026.06.023_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70251","article-title":"Targeting the GDF15 signalling for obesity treatment: recent advances and emerging challenges","volume":"28","author":"Zhang","year":"2024","journal-title":"J Cell Mol Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:29:03Z","timestamp":1787153343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1538783626004083"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.023","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}